stella
beta
Find trials matched to me
Trial Match
Phase I Study of Repotrectinib and Osimertinib in NSCLC Patients — Stella
Recruiting
Back to Nsclc trials
Phase 1 — Testing in a small group (usually 20–80 people) to find a safe dose and watch for side effects.
Trial locations
(4 sites)
Spain
Hospital Regional Universitario de Málaga, Málaga, Andalusia
Hospital Son Espases, Palma, Balearic Islands
Quiron Dexeus, Barcelona, Catalonia
Hospital Universitario Gregorio Marañón, Madrid
View full record on ClinicalTrials.gov